This is a very exciting time to be involved in cancer research!
We are excited to announce the 10th International Cancer Metastasis Congress, taking place on October 29th-31st, 2025, in San Francisco. This biennial event will bring together experts from around the world to share the latest advances in cancer metastasis research and treatment.
Since the inauguration of our biannual meeting on cancer metastasis in 2005, we have summarized these meetings in our textbook on Cancer Metastasis through the Lymphovascular System. We had a very successful meeting in 2023, which culminated in the publication of a Special Issue, entitled, Molecular Mechanisms of Cancer Metastasis, Clinical and Experimental Metastasis, Volume 41(4), 2024.
We will devote our 2025 Cancer Metastasis Congress to the Unifying Concept of Cancer Metastasis. A panel of distinguished experts in cancer metastasis has been chosen to serve on the organizing committee. The 2025 Cancer Metastasis Congress will bring together many renowned international experts in clinical oncology, immunobiology, pharmacology, molecular biology, and molecular imaging to discuss the molecular mechanisms of cancer metastasis and their clinical implications as we enter the era of precision medicine.
The conference emphasizes technology, experimental tools, molecular targets, translational research and clinical trials to define the molecular mechanisms of cancer metastasis so that more effective cancer therapy may be developed.
This meeting with the invited presentations will form the basis of a set of review articles to be published in the upcoming second edition of our book on Cancer Metastasis through the Lymphovascular System by Springer Nature in 2026.
With advancements in cancer care and patient-centered treatment planning, cancer survivors today live longer and enjoy a vastly improved quality of life than previously thought imaginable. We hope you will participate in the 10th International Congress on Cancer Metastasis, scheduled for October 29th-31st 2025 in San Francisco, California at the Hotel Nikko.
The Symposium is sponsored by the Sentinel Node Oncology Foundation, a 501(c)(3) non- profit organization founded in 2003 to advance the care and treatment of patients with solid cancer and to help develop new preventative strategies, diagnostics, and treatments. We will also have additional sponsors for this much anticipated meeting.
The Organizing Committee is building a program that follows the process of cancer metastasis from origins at the molecular level to genomic identification to precision treatment and survival. The theme of the Symposium is to track the single cell in our body, that has become a mutant cell, which proliferates with resultant mutants being selected to become the fittest clone to spread through the lymphovascular system using the sentinel lymph node as the major gateway to distant sites to cause devastation to the body. It is a journey that we must understand from a molecular level so that it can be stopped before the mutants go awry. It is the goal of this biennial symposium to bring together basic scientists, oncologists, surgeons, and radiologists from around the world, resulting in a cross-fertilization of ideas that will enhance the translation of basic science into clinical application-and challenge basic scientists with clinical issues.
In addition to plenary sessions with distinguished guest faculty, time will be allotted for integrated oral abstract presentations and poster sessions peer-selected from submitted abstracts by attendees, young investigators, and trainees.
A separate ballroom has been reserved for the poster sessions together with commercial exhibits and industry sponsored breakfast and lunch symposia on the most significant oncology topics related to late breaking results from clinical trials in cancer therapy.
We are confident that this two-day meeting in San Francisco will make a significant impact by updating the oncologists with the latest development in molecular mechanisms of cancer metastasis and cancer therapy thus, bringing the laboratory findings of cancer metastasis from the bench to the clinicians and clinical relevance of cancer metastasis to the basic scientists.
We look forward to seeing you in San Francisco!
Co-Chairs for the 2025 10th International Cancer Metastasis Congress
Stanley P. L. Leong, MD, Co-Chair
President, Sentinel Node Oncology Foundation
Chief of Cutaneous Oncology
Associate Director of the Melanoma Program Center for Melanoma
Research and Treatment California Pacific Medical Center
Senior Scientist California Pacific Medical Center Research Institute
S D Nathanson, MD, FACS, FSSO, Symposium Co-Chair
Surgical Oncologist and Chair, Breast Cancer Research
Breast Surgical Oncology, Henry Ford Health
Jonathan S. Zager, MD, FACS, FSSO, Co-Chair
Treasurer, Sentinel Node Oncology Foundation
Chief Academic Officer
Director of Regional Therapies
Senior Member, Departments of Cutaneous Oncology and Sarcoma, Moffitt Cancer Center
Chair, Department of Oncologic Sciences, University of South Florida Morsani College of Medicine
Professor of Surgery, University of South Florida Morsani College of Medicine
Share this: